Revolutionizing Drug Testing: The Future of Hybrid Methodologies

This chapter explores the innovative use of organoids, organ-on-a-chip technology, and AI in drug testing while addressing the limitations of animal testing. It discusses both the financial and ethical implications of adopting advanced models for drug development and highlights the impact of government funding cuts on research in this area. The conversation emphasizes the need for balancing cost-saving measures with patient accessibility and the potential loss of scientific talent due to funding uncertainty.